Estrella ImmunopharmaESLA
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 15 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, up 2 from Q3 2025. 6 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($700K), Renaissance Technologies ($191K) and Geode Capital Management, LLC ($171K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $205K |
| Exits | 2 | $5K |
All 13F filers, Q3 2025 → Q4 2025: 357,595 shares bought and 51,176 shares sold, net +306,419 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Vanguard Group Inc. | 0.00% | Add +6.9% | 448,765 | $700K |
| Renaissance Technologies | 0.00% | Add +1045.7% | 122,468 | $191K |
| Geode Capital Management, LLC | 0.00% | Add +8.2% | 109,808 | $171K |
| Citadel Advisors | 0.00% | Add +28.5% | 64,394 | $100K |
| Marshall Wace, LLP | 0.00% | New | 56,236 | $88K |
| XTX Topco Ltd | 0.00% | Add +376.9% | 49,472 | $77K |
| State Street Corp. | 0.00% | Add +93.5% | 43,252 | $67K |
| Quadrature Capital Ltd | 0.00% | New | 27,781 | $43K |
| BlackRock, Inc. | 0.00% | Add +9.9% | 26,470 | $41K |
| Northern Trust Corp. | 0.00% | New | 19,624 | $31K |
| Morgan Stanley | 0.00% | New | 11,097 | $17K |
| Jane Street Group, LLC | 0.00% | New | 10,441 | $16K |
| Royal Bank of Canada | 0.00% | New | 6,600 | $10K |
| UBS Group AG | 0.00% | Reduce -93.7% | 3,187 | $5K |
| Bank of America Corp. | 0.00% | Add +400.0% | 10 | $16 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.